Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

NCT05592223 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: BCG Vaccine USP
DRUG: Isoniazid
DRUG: Rifampin

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]